Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D K Ornstein

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Urology Reports|June 27, 2002
How to improve prostate biopsy detection of prostate cancerD K Ornstein, J Kang
Expert Opinion on Pharmacotherapy|March 16, 2001
Prostate-specific antigenD K Ornstein, R S Pruthi
BJU International|May 8, 1999
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancerD K Ornstein, J A Beiser, G L Andriole
Magnetic Resonance Imaging Clinics of North America|February 1, 1997
Renal masses: urologic managementD K Ornstein, C G Arcangeli, G L Andriole
Urology|December 4, 1998
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failedD K Ornstein, D S Smith, G L Andriole
The Journal of Urology|May 1, 1996
Metachronous presentation of bilateral Leydig cell tumorsD K Ornstein, S M Dierks, J W Colberg
JAMA|May 14, 1997
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsW J Catalona, D S Smith, D K Ornstein
The Urologic Clinics of North America|February 23, 1999
Evaluation and management of the man who has failed primary curative therapy for prostate cancerD K Ornstein, J Oh, J D Herschman, et al.
The Journal of Urology|March 1, 1997
The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostateD K Ornstein, G S Rao, D S Smith, et al.
The Journal of Urology|December 22, 1999
Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 coresC K Naughton, D K Ornstein, D S Smith, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Urology Reports|June 27, 2002
How to improve prostate biopsy detection of prostate cancerD K Ornstein, J Kang
Expert Opinion on Pharmacotherapy|March 16, 2001
Prostate-specific antigenD K Ornstein, R S Pruthi
BJU International|May 8, 1999
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancerD K Ornstein, J A Beiser, G L Andriole
Magnetic Resonance Imaging Clinics of North America|February 1, 1997
Renal masses: urologic managementD K Ornstein, C G Arcangeli, G L Andriole
Urology|December 4, 1998
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failedD K Ornstein, D S Smith, G L Andriole
The Journal of Urology|May 1, 1996
Metachronous presentation of bilateral Leydig cell tumorsD K Ornstein, S M Dierks, J W Colberg
JAMA|May 14, 1997
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurementsW J Catalona, D S Smith, D K Ornstein
The Urologic Clinics of North America|February 23, 1999
Evaluation and management of the man who has failed primary curative therapy for prostate cancerD K Ornstein, J Oh, J D Herschman, et al.
The Journal of Urology|March 1, 1997
The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostateD K Ornstein, G S Rao, D S Smith, et al.
The Journal of Urology|December 22, 1999
Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 coresC K Naughton, D K Ornstein, D S Smith, et al.
Pageof 4